GlobeNewswire Inc | Mar 16, 2021 04:01PM EDT

March 16, 2021

TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the year ended December 31, 2020 after the market close on Thursday, March 25, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast DetailsDate: Thursday, March 25Time: 4:30 pm Eastern TimeToll Free: 877-407-0789International: 201-689-8562Conference ID: 13715845Webcast: http://public.viavid.com/index.php?id=143331

About HTGHTG is focused on NGS-based molecular profiling. The companys proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTGs customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

Contact:Ashley R. RobinsonLifeSci Advisors, LLCPhone: (617) 430-7577Email:arr@lifesciadvisors.com